COMT and Parkinson disease: Entacapone, a catechol‐O‐methyltransferase (COMT) inhibitor, reduces peripheral catabolism of L‐DOPA and improves its effective delivery to the brain, and has subsequent clinical effects, in PD patients with motor fluctuations (Lees, 2008).